zenodoopen
Population Statistics on NCT02332590
<p>Data presented as mean or median (change), in parts with quantiles (Q1, Q3) published by</p> <table> <tbody> <tr> <td> <p>C. Gaby, G. Burmester, V. Strand, J. Msihid, M. Zilberstein, T. Kimura, B. van Hoogstraten, S. H. Boklage, J. Sadeh, M. H. G. Neil and A. Boyapati, "Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes," <em>Arthritis Research & Therapy, </em>vol. 22, no. 1, p. 70, 2020.</p> </td> </tr> </tbody> </table>
ShareScore
44/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 8
- Access
- 16
- Reuse readiness
- 8
- Engagement
- 0